Answers are grounded in this paper and cite their sources.
Rationale: Neonatal lupus erythematosus (NLE) is caused by transplacental transfer of maternal autoantibodies against SS-A, SS-B, and/or RNP. Symptoms include heart block, skin lesions, cytopenia, liver dysfunction, and occasionally hydrocephalus. Hepatobiliary disease in NLE should be closely monitored, since severe liver failure has been reported. Patient concerns: A 0-day-old female patient presented with nonspecific systemic erythema, liver dysfunction, and hyperferritinemia at birth, and abdominal magnetic resonance imaging indicated diffuse iron deposition in the liver but not in extrahepatic tissues. The patient had no maternal complications or findings indicating intrauterine growth retardation, oligohydramnios, or fetal ascites. Diagnoses: The patient was diagnosed with NLE based on the presence of anti-SS-A and SS-B antibodies in the maternal and cord blood. Interventions: No intervention was required. Outcomes: Her symptoms improved spontaneously. The titers of anti-SS-A and SS-B antibodies became undetectable levels on day 379, while serum anti-double stranded DNA antibody became positive without any clinical symptoms. Lessons: Since NLE with hepatobiliary disease could present with diffuse iron deposition in the liver mimicking neonatal hemochromatosis, we need to carefully evaluate and monitor this condition.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: